Stay updated on CX-072 Dose-finding Clinical Trial
Sign up to get notified when there's something new on the CX-072 Dose-finding Clinical Trial page.

Latest updates to the CX-072 Dose-finding Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the terminated CX-072 study is displayed, with its eligibility criteria, study locations, design, outcomes, results-related dates, publications, and study documents.SummaryDifference73%

- Check18 days agoChange DetectedThe displayed site revision changes from v3.7.2 to v3.8.0; the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedAn NIH-wide banner announces website transition updates and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedAccess to the study record now displays a 403 Forbidden error page, with the typical site header and footer but no study content. This indicates restricted access or a broken link rather than an update to study data.SummaryDifference19%

Stay in the know with updates to CX-072 Dose-finding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CX-072 Dose-finding Clinical Trial page.